SCHEMBL30616273

SCHEMBL30616273

COC(=O)c1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c2cc1C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 16/20 0.82
▸ MET P08581 13/20 0.82
▸ KDR P35968 5/20 0.77
▸ MERTK Q12866 7/20 0.75
▸ RET P07949 4/20 0.64
▸ KIT P10721 4/20 0.64
▸ FLT3 P36888 4/20 0.64
▸ HDAC2 Q92769 2/20 0.64
▸ HDAC8 Q9BY41 2/20 0.64
▸ HDAC6 Q9UBN7 2/20 0.64
▸ PDGFRB P09619 2/20 0.64
▸ HDAC10 Q969S8 1/20 0.62
▸ HDAC11 Q96DB2 1/20 0.62
▸ AURKA O14965 2/20 0.62
▸ RIPK2 O43353 2/20 0.62
▸ ABL1 P00519 2/20 0.62
▸ EGFR P00533 2/20 0.62
▸ ERBB2 P04626 2/20 0.62
▸ NTRK1 P04629 2/20 0.62
▸ LCK P06239 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21200784 1.00 AXL (0.82) AXLMETKDRMERTKRET
SCHEMBL21201112 0.92 AXL (0.81) AXLMETKDRMERTKRET
SCHEMBL21201203 0.92 AXL (0.74) AXLMETKDRMERTKRET
SCHEMBL30152436 0.91 AXL (0.83) AXLMETKDRMERTKRET
SCHEMBL21200755 0.91 AXL (0.83) AXLMETKDRMERTKRET
SCHEMBL30152581 0.91 AXL (0.87) AXLMETKDRMERTKRET
SCHEMBL21201030 0.91 AXL (0.87) AXLMETKDRMERTKRET
SCHEMBL30152509 0.91 AXL (1.00) AXLMETKDRMERTKRET
SCHEMBL21200864 0.91 AXL (1.00) AXLMETKDRMERTKRET
SCHEMBL21200722 0.88 MET (0.82) AXLMETKDRMERTKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820226-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-04-05 — — CN disclosed
CN-117624045-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-03-01 — — CN disclosed
CN-117603138-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-02-27 — — CN disclosed
CN-111757735-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2023-09-22 — — CN disclosed
Send feedback